Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Naion Is More Common with Semaglutide

Summary by Deutsches Ärzteblatt
Palo Alto – For just over a year, reports of ocular side effects from GLP-1 receptor agonists (GLP-1 RAs), especially semaglutide, have been increasing. Most of these involve non-arteritic anterior ischemic optic neuropathy (NAION), which can potentially lead to blindness. A study now published in JAMA Ophthalmology (2026; DOI:...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

Deutsches ÄrzteblattDeutsches Ärzteblatt

Naion Is More Common with Semaglutide

Palo Alto – For just over a year, reports of ocular side effects from GLP-1 receptor agonists (GLP-1 RAs), especially semaglutide, have been increasing. Most of these involve non-arteritic anterior ischemic optic neuropathy (NAION), which can potentially lead to blindness. A study now published in JAMA Ophthalmology (2026; DOI:...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news in on Monday, February 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal